Compound Evidence File
#EC-2026-0558
Superdrol
Filed under Oral Tablets. The bureau holds 156 laboratory returns for this compound from 57 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
57 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Dec 2025 | 12 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Jan 2026 | 23 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Apr 2026 | 6 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Feb 2026 | 7 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Jan 2026 | 8 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 7 Mar 2026 | 9 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 20 Apr 2026 | 5 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Dec 2025 | 6 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 27 Feb 2026 | 12 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 5 Dec 2025 | 12 Mar 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 24 Dec 2025 | 11 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Mar 2026 | 7 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Feb 2026 | 18 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Dec 2025 | 26 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 19 Apr 2026 | 18 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 5 May 2026 | 25 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 10 May 2026 | 26 May 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 20 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 25 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 11 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 9.9 | 10 May 2026 | 16 Aug 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.3 | 9.3 | 9.3 | 2 Apr 2025 | 2 Apr 2025 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 | 25 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.4 | 8.1 | 8.6 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.2 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.2 | 7.2 | 9.2 | 24 May 2026 | 24 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 5 | 8.2 | 6.5 | 9.6 | 3 Jul 2025 | 21 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 | 11 Jun 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 7.8 | 6.2 | 9.1 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 7.7 | 7.2 | 8.1 | 21 May 2026 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 6 | 7.7 | 6.5 | 10.0 | 21 May 2025 | 24 May 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 | 21 May 2025 |
| PurePeptidesCASE #VI-2026-0234 | X | 1 | 7.2 | 7.2 | 7.2 | 28 Mar 2025 | 28 Mar 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 3 | 7.0 | 5.6 | 8.6 | 21 May 2025 | 19 Jan 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 | 14 Jan 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 | 9 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 6.6 | 6.6 | 6.6 | 17 Dec 2024 | 17 Dec 2024 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 6.5 | 5.1 | 8.8 | 9 Jun 2025 | 25 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 4 | 6.2 | 5.6 | 7.5 | 8 Jul 2025 | 19 Jan 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 4 | 6.2 | 3.0 | 9.8 | 28 Mar 2025 | 21 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.1 | 6.1 | 6.1 | 14 Jan 2025 | 14 Jan 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 5.8 | 4.4 | 7.2 | 2 Jul 2025 | 21 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 5.7 | 5.7 | 5.7 | 28 Mar 2025 | 28 Mar 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 5.5 | 5.5 | 5.5 | 20 Jun 2025 | 20 Jun 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 | 3 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 2 | 4.4 | 4.0 | 4.8 | 3 Jul 2025 | 24 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 3.6 | 3.6 | 3.6 | 2 Apr 2025 | 2 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 1.1 | 1.1 | 1.1 | 24 Apr 2025 | 24 Apr 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 1.1 | 1.1 | 1.1 | 3 Jun 2025 | 3 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.1 | 0.1 | 0.1 | 20 Jun 2025 | 20 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for Superdrol alone.